Internal Medicine, Interventional Cardiology · Thousand Oaks, CA
NPI
1962404723
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2220 Lynn Rd, Suite 208
Thousand Oaks, CA, 91360
Phone (805) 494-9494
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
12,326 services
Medicare patients, 2024
2,076
Average age 78
Drug cost, 2024
$2.1M
10,473 prescriptions
Company payments, 2025
$1,507
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David G Aliabadi was code 99214 (office e&m - established), 3,004 times for 1,782 patients. In total David G Aliabadi billed 12,326 services in 39 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 3,004 | 1,782 | $98.69 | $296K |
| 93000 Electrocardiogram | Office | 2,530 | 1,889 | $11.28 | $29K |
| 99213 Office E&M - Established | Office | 1,306 | 882 | $70.66 | $92K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,081 | 267 | $6.89 | $7,446 |
| 93306 Echocardiography (TTE/TEE) | Office | 919 | 804 | $163.94 | $151K |
| 93015 Electrocardiogram | Office | 532 | 494 | $61.32 | $33K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 526 | 262 | $399.59 | $210K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 437 | 434 | $160.30 | $70K |
| 93280 External Electrocardiographic Monitoring | Office | 321 | 156 | $64.66 | $21K |
| 78492 Myocardial Perfusion Scan | Office | 263 | 262 | $1,311.78 | $345K |
| 99215 Office E&M - Established | Office | 249 | 230 | $137.96 | $34K |
| 99205 Office E&M - New | Office | 218 | 218 | $159.24 | $35K |
| 93242 Electrocardiogram | Office | 194 | 178 | $10.69 | $2,073 |
| 93244 Electrocardiogram | Office | 194 | 178 | $18.18 | $3,528 |
| 93291 External Electrocardiographic Monitoring | Office | 158 | 26 | $40.66 | $6,424 |
By year: 2022 $1.1M for 12,029 services; 2023 $1.3M for 11,932 services; 2024 $1.4M for 12,326 services.
Medicare prescription drug claims, 2024
In 2024, the drug David G Aliabadi prescribed most often to Medicare patients was Atorvastatin Calcium, with 831 prescriptions and refills. In total David G Aliabadi wrote 10,473 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 831 | 2,421 | 245 | $6,993 |
| Amlodipine Besylate Generic | 702 | 1,951 | 223 | $6,400 |
| Metoprolol Succinate Generic | 680 | 1,892 | 190 | $12K |
| Eliquis Apixaban | 602 | 1,220 | 150 | $702K |
| Losartan Potassium Generic | 569 | 1,643 | 174 | $6,461 |
| Rosuvastatin Calcium Generic | 565 | 1,634 | 180 | $6,238 |
| Hydrochlorothiazide Generic | 533 | 1,545 | 176 | $3,232 |
| Repatha Sureclick Evolocumab | 429 | 853 | 92 | $476K |
| Metoprolol Tartrate Generic | 398 | 1,103 | 143 | $3,199 |
| Simvastatin Generic | 348 | 998 | 95 | $2,617 |
| Carvedilol Generic | 322 | 906 | 92 | $3,089 |
| Ezetimibe Generic | 319 | 898 | 96 | $7,193 |
| Lisinopril Generic | 245 | 698 | 67 | $2,158 |
| Furosemide Generic | 219 | 535 | 69 | $1,096 |
| Xarelto Rivaroxaban | 165 | 410 | 48 | $226K |
Brand drugs: 1,797 claims; generic drugs: 8,676 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David G Aliabadi $1,507 ($1,507 in general payments such as food, travel and fees) from 13 companies. The largest payer was Impulse Dynamics (USA) Inc. with $286.
| Company | Payments | Amount |
|---|---|---|
| Impulse Dynamics (USA) Inc. | 2 | $286 |
| Medtronic, Inc. MDT | 12 | $216 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $197 |
| Merck Sharp & Dohme LLC MRK | 6 | $174 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $143 |
| Boston Scientific Corporation BSX | 3 | $106 |
| Cleerly, Inc. | 1 | $100 |
| Pfizer Inc. PFE | 4 | $86.63 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $64.48 |
| Biotronik Inc. | 3 | $63.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.